<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-12-06" modified="2019-07-03" version="106">
<accession>P0AE70</accession>
<accession>P33645</accession>
<accession>Q2MA50</accession>
<name>MAZF_ECOLI</name>
<protein>
<recommendedName>
<fullName>Endoribonuclease toxin MazF</fullName>
<ecNumber evidence="9">3.1.27.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Toxin MazF</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="31">mRNA interferase MazF</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">mazF</name>
<name type="synonym">chpA</name>
<name type="synonym">chpAK</name>
<name type="ordered locus">b2782</name>
<name type="ordered locus">JW2753</name>
</gene>
<organism>
<name type="scientific">Escherichia coli (strain K12)</name>
<dbReference type="NCBI Taxonomy" id="83333"/>
<lineage>
<taxon>Bacteria</taxon>
<taxon>Proteobacteria</taxon>
<taxon>Gammaproteobacteria</taxon>
<taxon>Enterobacterales</taxon>
<taxon>Enterobacteriaceae</taxon>
<taxon>Escherichia</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="J. Biol. Chem." volume="263" first="15699" last="15704">
<title>The nucleotide sequence and characterization of the relA gene of Escherichia coli.</title>
<authorList>
<person name="Metzger S."/>
<person name="Dror I.B."/>
<person name="Aizenman E."/>
<person name="Schreiber G."/>
<person name="Toone M."/>
<person name="Friesen J.D."/>
<person name="Cashel M."/>
<person name="Glaser G."/>
</authorList>
<dbReference type="PubMed" id="2844820"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>OPERON STRUCTURE</scope>
<source>
<strain>K12</strain>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="J. Bacteriol." volume="175" first="6850" last="6856">
<title>chpA and chpB, Escherichia coli chromosomal homologs of the pem locus responsible for stable maintenance of plasmid R100.</title>
<authorList>
<person name="Masuda Y."/>
<person name="Miyakawa K."/>
<person name="Nishimura Y."/>
<person name="Ohtsubo E."/>
</authorList>
<dbReference type="PubMed" id="8226627"/>
<dbReference type="DOI" id="10.1128/jb.175.21.6850-6856.1993"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<strain>K12 / MC1000 / ATCC 39531</strain>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Science" volume="277" first="1453" last="1462">
<title>The complete genome sequence of Escherichia coli K-12.</title>
<authorList>
<person name="Blattner F.R."/>
<person name="Plunkett G. III"/>
<person name="Bloch C.A."/>
<person name="Perna N.T."/>
<person name="Burland V."/>
<person name="Riley M."/>
<person name="Collado-Vides J."/>
<person name="Glasner J.D."/>
<person name="Rode C.K."/>
<person name="Mayhew G.F."/>
<person name="Gregor J."/>
<person name="Davis N.W."/>
<person name="Kirkpatrick H.A."/>
<person name="Goeden M.A."/>
<person name="Rose D.J."/>
<person name="Mau B."/>
<person name="Shao Y."/>
</authorList>
<dbReference type="PubMed" id="9278503"/>
<dbReference type="DOI" id="10.1126/science.277.5331.1453"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / MG1655 / ATCC 47076</strain>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Mol. Syst. Biol." volume="2" first="E1" last="E5">
<title>Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110.</title>
<authorList>
<person name="Hayashi K."/>
<person name="Morooka N."/>
<person name="Yamamoto Y."/>
<person name="Fujita K."/>
<person name="Isono K."/>
<person name="Choi S."/>
<person name="Ohtsubo E."/>
<person name="Baba T."/>
<person name="Wanner B.L."/>
<person name="Mori H."/>
<person name="Horiuchi T."/>
</authorList>
<dbReference type="PubMed" id="16738553"/>
<dbReference type="DOI" id="10.1038/msb4100049"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="6059" last="6063">
<title>An Escherichia coli chromosomal 'addiction module' regulated by guanosine 3',5'-bispyrophosphate: a model for programmed bacterial cell death.</title>
<authorList>
<person name="Aizenman E."/>
<person name="Engelberg-Kulka H."/>
<person name="Glaser G."/>
</authorList>
<dbReference type="PubMed" id="8650219"/>
<dbReference type="DOI" id="10.1073/pnas.93.12.6059"/>
</citation>
<scope>FUNCTION IN PROGRAMMED CELL DEATH</scope>
<scope>INTERACTION WITH MAZE</scope>
<scope>INDUCTION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<scope>OPERON STRUCTURE</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="5975" last="5984">
<title>The regulation of the Escherichia coli mazEF promoter involves an unusual alternating palindrome.</title>
<authorList>
<person name="Marianovsky I."/>
<person name="Aizenman E."/>
<person name="Engelberg-Kulka H."/>
<person name="Glaser G."/>
</authorList>
<dbReference type="PubMed" id="11071896"/>
<dbReference type="DOI" id="10.1074/jbc.M008832200"/>
</citation>
<scope>TRANSCRIPTION REGULATION</scope>
<scope>SUBUNIT</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="J. Bacteriol." volume="183" first="2041" last="2045">
<title>Programmed cell death in Escherichia coli: some antibiotics can trigger mazEF lethality.</title>
<authorList>
<person name="Sat B."/>
<person name="Hazan R."/>
<person name="Fisher T."/>
<person name="Khaner H."/>
<person name="Glaser G."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="11222603"/>
<dbReference type="DOI" id="10.1128/JB.183.6.2041-2045.2001"/>
</citation>
<scope>FUNCTION IN CELL DEATH</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="Mol. Microbiol." volume="45" first="501" last="510">
<title>Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins.</title>
<authorList>
<person name="Pedersen K."/>
<person name="Christensen S.K."/>
<person name="Gerdes K."/>
</authorList>
<dbReference type="PubMed" id="12123459"/>
<dbReference type="DOI" id="10.1046/j.1365-2958.2002.03027.x"/>
</citation>
<scope>FUNCTION AS A TOXIN</scope>
<source>
<strain>K12</strain>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="J. Mol. Biol." volume="332" first="809" last="819">
<title>Toxin-antitoxin loci as stress-response-elements: ChpAK/MazF and ChpBK cleave translated RNAs and are counteracted by tmRNA.</title>
<authorList>
<person name="Christensen S.K."/>
<person name="Pedersen K."/>
<person name="Hansen F.G."/>
<person name="Gerdes K."/>
</authorList>
<dbReference type="PubMed" id="12972253"/>
<dbReference type="DOI" id="10.1016/S0022-2836(03)00922-7"/>
</citation>
<scope>RNA CLEAVAGE</scope>
<scope>INDUCTION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<source>
<strain>K12 / MG1655 / ATCC 47076</strain>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="J. Bacteriol." volume="186" first="3663" last="3669">
<title>Escherichia coli mazEF-mediated cell death is triggered by various stressful conditions.</title>
<authorList>
<person name="Hazan R."/>
<person name="Sat B."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="15150257"/>
<dbReference type="DOI" id="10.1128/JB.186.11.3663-3669.2004"/>
</citation>
<scope>DISRUPTION PHENOTYPE</scope>
<scope>FUNCTION IN STRESS RESPONSE</scope>
<scope>DEPENDENCE ON RELA</scope>
<source>
<strain>K12 / K38 / S26</strain>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="J. Bacteriol." volume="186" first="8295" last="8300">
<title>MazF-mediated cell death in Escherichia coli: a point of no return.</title>
<authorList>
<person name="Amitai S."/>
<person name="Yassin Y."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="15576778"/>
<dbReference type="DOI" id="10.1128/JB.186.24.8295-8300.2004"/>
</citation>
<scope>FUNCTION IN PROGRAMMED CELL DEATH</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Mol. Genet. Genomics" volume="272" first="227" last="234">
<title>Escherichia coli mazEF-mediated cell death as a defense mechanism that inhibits the spread of phage P1.</title>
<authorList>
<person name="Hazan R."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="15316771"/>
<dbReference type="DOI" id="10.1007/s00438-004-1048-y"/>
</citation>
<scope>FUNCTION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<source>
<strain>K12 / JM109 / ATCC 53323</strain>
<strain>K12 / K38 / S26</strain>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="3143" last="3150">
<title>Insights into the mRNA cleavage mechanism by MazF, an mRNA interferase.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Zhang J."/>
<person name="Hara H."/>
<person name="Kato I."/>
<person name="Inouye M."/>
</authorList>
<dbReference type="PubMed" id="15537630"/>
<dbReference type="DOI" id="10.1074/jbc.M411811200"/>
</citation>
<scope>FUNCTION AS AN ENDONUCLEASE</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBSTRATE SPECIFICITY</scope>
<scope>RNA-BINDING</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="Mol. Cell" volume="18" first="253" last="261">
<title>Single protein production in living cells facilitated by an mRNA interferase.</title>
<authorList>
<person name="Suzuki M."/>
<person name="Zhang J."/>
<person name="Liu M."/>
<person name="Woychik N.A."/>
<person name="Inouye M."/>
</authorList>
<dbReference type="PubMed" id="15837428"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.03.011"/>
</citation>
<scope>BIOTECHNOLOGY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Mol. Microbiol." volume="59" first="590" last="601">
<title>MazG -- a regulator of programmed cell death in Escherichia coli.</title>
<authorList>
<person name="Gross M."/>
<person name="Marianovsky I."/>
<person name="Glaser G."/>
</authorList>
<dbReference type="PubMed" id="16390452"/>
<dbReference type="DOI" id="10.1111/j.1365-2958.2005.04956.x"/>
</citation>
<scope>INDUCTION</scope>
<scope>OPERON STRUCTURE</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="Science" volume="318" first="652" last="655">
<title>A linear pentapeptide is a quorum-sensing factor required for mazEF-mediated cell death in Escherichia coli.</title>
<authorList>
<person name="Kolodkin-Gal I."/>
<person name="Hazan R."/>
<person name="Gaathon A."/>
<person name="Carmeli S."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="17962566"/>
<dbReference type="DOI" id="10.1126/science.1147248"/>
</citation>
<scope>REQUIREMENT FOR EXTRACELLULAR DEATH FACTOR (EDF)</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="J. Bacteriol." volume="190" first="3169" last="3175">
<title>The extracellular death factor: physiological and genetic factors influencing its production and response in Escherichia coli.</title>
<authorList>
<person name="Kolodkin-Gal I."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="18310334"/>
<dbReference type="DOI" id="10.1128/JB.01918-07"/>
</citation>
<scope>EDF PRODUCTION</scope>
<scope>STRAIN DIFFERENCES IN ABILITY TO MAKE AND RESPOND TO EDF</scope>
<source>
<strain>K12 / K38 / S26</strain>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
<strain>K12 / MG1655 / ATCC 47076</strain>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Nucleic Acids Res." volume="36" first="6472" last="6481">
<title>Translation affects YoeB and MazF messenger RNA interferase activities by different mechanisms.</title>
<authorList>
<person name="Christensen-Dalsgaard M."/>
<person name="Gerdes K."/>
</authorList>
<dbReference type="PubMed" id="18854355"/>
<dbReference type="DOI" id="10.1093/nar/gkn667"/>
</citation>
<scope>TRANSLATION IMPROVES CLEAVAGE EFFICIENCY</scope>
<source>
<strain>K12</strain>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="J. Bacteriol." volume="191" first="3177" last="3182">
<title>The stationary-phase sigma factor sigma(S) is responsible for the resistance of Escherichia coli stationary-phase cells to mazEF-mediated cell death.</title>
<authorList>
<person name="Kolodkin-Gal I."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="19251848"/>
<dbReference type="DOI" id="10.1128/JB.00011-09"/>
</citation>
<scope>FUNCTION</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E6785" last="E6785">
<title>A differential effect of E. coli toxin-antitoxin systems on cell death in liquid media and biofilm formation.</title>
<authorList>
<person name="Kolodkin-Gal I."/>
<person name="Verdiger R."/>
<person name="Shlosberg-Fedida A."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="19707553"/>
<dbReference type="DOI" id="10.1371/journal.pone.0006785"/>
</citation>
<scope>FUNCTION IN CELL DEATH</scope>
<scope>FUNCTION IN BIOFILM FORMATION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="Cell" volume="147" first="147" last="157">
<title>Selective translation of leaderless mRNAs by specialized ribosomes generated by MazF in Escherichia coli.</title>
<authorList>
<person name="Vesper O."/>
<person name="Amitai S."/>
<person name="Belitsky M."/>
<person name="Byrgazov K."/>
<person name="Kaberdina A.C."/>
<person name="Engelberg-Kulka H."/>
<person name="Moll I."/>
</authorList>
<dbReference type="PubMed" id="21944167"/>
<dbReference type="DOI" id="10.1016/j.cell.2011.07.047"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBSTRATE SPECIFICITY</scope>
<scope>TRANSLATION REGULATION</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="Mol. Cell" volume="41" first="625" last="635">
<title>The Escherichia coli extracellular death factor EDF induces the endoribonucleolytic activities of the toxins MazF and ChpBK.</title>
<authorList>
<person name="Belitsky M."/>
<person name="Avshalom H."/>
<person name="Erental A."/>
<person name="Yelin I."/>
<person name="Kumar S."/>
<person name="London N."/>
<person name="Sperber M."/>
<person name="Schueler-Furman O."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="21419338"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.02.023"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>INTERACTION WITH EDF</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="13206" last="13211">
<title>Bacterial persistence by RNA endonucleases.</title>
<authorList>
<person name="Maisonneuve E."/>
<person name="Shakespeare L.J."/>
<person name="Joergensen M.G."/>
<person name="Gerdes K."/>
</authorList>
<dbReference type="PubMed" id="21788497"/>
<dbReference type="DOI" id="10.1073/pnas.1100186108"/>
</citation>
<scope>FUNCTION IN PERSISTENCE</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<source>
<strain>K12 / MG1655 / ATCC 47076</strain>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Mol. Cell" volume="36" first="845" last="860">
<title>Hydroxyurea induces hydroxyl radical-mediated cell death in Escherichia coli.</title>
<authorList>
<person name="Davies B.W."/>
<person name="Kohanski M.A."/>
<person name="Simmons L.A."/>
<person name="Winkler J.A."/>
<person name="Collins J.J."/>
<person name="Walker G.C."/>
</authorList>
<dbReference type="PubMed" id="20005847"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.11.024"/>
</citation>
<scope>FUNCTION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2012" name="PLoS Biol." volume="10" first="E1001281" last="E1001281">
<title>Two programmed cell death systems in Escherichia coli: an apoptotic-like death is inhibited by the mazEF-mediated death pathway.</title>
<authorList>
<person name="Erental A."/>
<person name="Sharon I."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="22412352"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1001281"/>
</citation>
<scope>FUNCTION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2013" name="BMC Microbiol." volume="13" first="45" last="45">
<title>Transcriptional cross-activation between toxin-antitoxin systems of Escherichia coli.</title>
<authorList>
<person name="Kasari V."/>
<person name="Mets T."/>
<person name="Tenson T."/>
<person name="Kaldalu N."/>
</authorList>
<dbReference type="PubMed" id="23432955"/>
<dbReference type="DOI" id="10.1186/1471-2180-13-45"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION BY OTHER TA SYSTEMS</scope>
<source>
<strain>K12 / BW25113</strain>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2013" name="Cell Rep." volume="3" first="528" last="537">
<title>YihE kinase is a central regulator of programmed cell death in bacteria.</title>
<authorList>
<person name="Dorsey-Oresto A."/>
<person name="Lu T."/>
<person name="Mosel M."/>
<person name="Wang X."/>
<person name="Salz T."/>
<person name="Drlica K."/>
<person name="Zhao X."/>
</authorList>
<dbReference type="PubMed" id="23416055"/>
<dbReference type="DOI" id="10.1016/j.celrep.2013.01.026"/>
</citation>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<source>
<strain>K12 / MG1655 / ATCC 47076</strain>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="Proteins" volume="81" first="874" last="883">
<title>ACA-specific RNA sequence recognition is acquired via the loop 2 region of MazF mRNA interferase.</title>
<authorList>
<person name="Park J.H."/>
<person name="Yoshizumi S."/>
<person name="Yamaguchi Y."/>
<person name="Wu K.P."/>
<person name="Inouye M."/>
</authorList>
<dbReference type="PubMed" id="23280569"/>
<dbReference type="DOI" id="10.1002/prot.24246"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBSTRATE SPECIFICITY</scope>
<scope>DOMAIN</scope>
<scope>MUTAGENESIS OF 17-PHE--HIS-28 AND 53-THR--GLU-61</scope>
<source>
<strain>K12 / BW25113</strain>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="4191" last="4205">
<title>MazF-induced growth inhibition and persister generation in Escherichia coli.</title>
<authorList>
<person name="Tripathi A."/>
<person name="Dewan P.C."/>
<person name="Siddique S.A."/>
<person name="Varadarajan R."/>
</authorList>
<dbReference type="PubMed" id="24375411"/>
<dbReference type="DOI" id="10.1074/jbc.M113.510511"/>
</citation>
<scope>FUNCTION IN PERSISTENCE</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<scope>MUTAGENESIS OF GLU-24 AND HIS-28</scope>
<source>
<strain>K12 / BW25113</strain>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2015" name="Nucleic Acids Res." volume="43" first="1241" last="1256">
<title>Escherichia coli antitoxin MazE as transcription factor: insights into MazE-DNA binding.</title>
<authorList>
<person name="Zorzini V."/>
<person name="Buts L."/>
<person name="Schrank E."/>
<person name="Sterckx Y.G."/>
<person name="Respondek M."/>
<person name="Engelberg-Kulka H."/>
<person name="Loris R."/>
<person name="Zangger K."/>
<person name="van Nuland N.A."/>
</authorList>
<dbReference type="PubMed" id="25564525"/>
<dbReference type="DOI" id="10.1093/nar/gku1352"/>
</citation>
<scope>FUNCTION IN TRANSCRIPTION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="Prog. Mol. Biol. Transl. Sci." volume="85" first="467" last="500">
<title>mRNA interferases, sequence-specific endoribonucleases from the toxin-antitoxin systems.</title>
<authorList>
<person name="Yamaguchi Y."/>
<person name="Inouye M."/>
</authorList>
<dbReference type="PubMed" id="19215780"/>
<dbReference type="DOI" id="10.1016/S0079-6603(08)00812-X"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2016" name="Mol. Microbiol." volume="99" first="188" last="198">
<title>An ADP-ribosyltransferase Alt of bacteriophage T4 negatively regulates the Escherichia coli MazF toxin of a toxin-antitoxin module.</title>
<authorList>
<person name="Alawneh A.M."/>
<person name="Qi D."/>
<person name="Yonesaki T."/>
<person name="Otsuka Y."/>
</authorList>
<dbReference type="PubMed" id="26395283"/>
<dbReference type="DOI" id="10.1111/mmi.13225"/>
</citation>
<scope>ACTIVITY REGULATION (MICROBIAL INFECTION)</scope>
<scope>ADP-RIBOSYLATION AT ARG-4 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2003" name="Mol. Cell" volume="11" first="875" last="884">
<title>Crystal structure of the MazE/MazF complex: molecular bases of antidote-toxin recognition.</title>
<authorList>
<person name="Kamada K."/>
<person name="Hanaoka F."/>
<person name="Burley S.K."/>
</authorList>
<dbReference type="PubMed" id="12718874"/>
<dbReference type="DOI" id="10.1016/S1097-2765(03)00097-2"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 2-111</scope>
<scope>POSSIBLE DNA-BINDING</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="J. Mol. Biol." volume="357" first="139" last="150">
<title>Characterization of dual substrate binding sites in the homodimeric structure of Escherichia coli mRNA interferase MazF.</title>
<authorList>
<person name="Li G.Y."/>
<person name="Zhang Y."/>
<person name="Chan M.C."/>
<person name="Mal T.K."/>
<person name="Hoeflich K.P."/>
<person name="Inouye M."/>
<person name="Ikura M."/>
</authorList>
<dbReference type="PubMed" id="16413577"/>
<dbReference type="DOI" id="10.1016/j.jmb.2005.12.035"/>
</citation>
<scope>STRUCTURE BY NMR</scope>
<scope>MUTAGENESIS OF GLU-24</scope>
</reference>
<reference key="35">
<citation type="submission" date="2010-06" db="PDB data bank">
<title>Biochemical and structural analysis of E. coli MazF toxin.</title>
<authorList>
<person name="Wang X."/>
<person name="Wang K."/>
<person name="Gao X."/>
<person name="Zhang X."/>
<person name="Li L."/>
<person name="Su X."/>
<person name="Zhang J."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS)</scope>
</reference>
<comment type="function">
<text evidence="3 4 7 9 15 16 21 23 25 27 30">Toxic component of a type II toxin-antitoxin (TA) system. A sequence-specific endoribonuclease it inhibits protein synthesis by cleaving mRNA and inducing bacterial stasis. It is stable, single-strand specific with mRNA cleavage independent of the ribosome, although translation enhances cleavage for some mRNAs (PubMed:18854355). Cleavage occurs at the 5'-end of ACA sequences, yielding a 2',3'-cyclic phosphate and a free 5'-OH, although cleavage can also occur on the 3'-end of the first A (PubMed:15537630, PubMed:23280569). Digests 16S rRNA in vivo 43 nts upstream of the C-terminus; this removes the anti-Shine-Dalgarno sequence forming a mixed population of wild-type and "stress ribosomes". Stress ribosomes do not translate leader-containing mRNA but are proficient in translation of leaderless mRNA, which alters the protein expression profile of the cell; MazF produces some leaderless mRNA (PubMed:21944167). The toxic endoribonuclease activity is inhibited by its labile cognate antitoxin MazE. Toxicity results when the levels of MazE decrease in the cell, leading to mRNA degradation. This effect can be rescued by expression of MazE, but after 6 hours in rich medium overexpression of MazF leads to programmed cell death (PubMed:8650219, PubMed:11222603). MazF-mediated cell death occurs following a number of stress conditions in a relA-dependent fashion and only when cells are in log phase; sigma factor S (rpoS) protects stationary phase cells from MazF-killing (PubMed:15150257, PubMed:19251848). Cell growth and viability are not affected when MazF and MazE are coexpressed. Both MazE and MazE-MazF bind to the promoter region of the mazE-mazF operon to inhibit their own transcription. MazE has higher affinity for promoter DNA in the presence of MazF (PubMed:25564525). Cross-talk can occur between different TA systems, ectopic expression of this toxin induces transcription of the relBEF TA system operon with specific cleavage of the mRNA produced (PubMed:23432955).</text>
</comment>
<comment type="function">
<text evidence="8">Might also serve to protect cells against bacteriophage; in the presence of MazE-MazF fewer P1 phages are produced than in a disrupted strain. For strain K38 most wild-type cells are killed but not by phage lysis; it was suggested that MazE-MazF causes P1 phage exclusion from the bacterial population. This phenomenon is strain dependent.</text>
</comment>
<comment type="function">
<text evidence="13 14 17 18 19 20 22 24 26 30">The physiological role of this TA system is debated. Programmed cell death (PCD) occurs when cells are at high density and depends on the presence of MazE-MazF and a quorum sensing pentapeptide, the extracellular death factor (EDF) with sequence Asn-Asn-Trp-Asn-Asn (NNWNN), probably produced from the zwf gene product glucose-6-phosphate 1-dehydrogenase (PubMed:17962566, PubMed:18310334). Cell death governed by the MazE-MazF and DinJ-YafQ TA systems seems to play a role in biofilm formation, while MazE-MazF is also implicated in cell death in liquid media (PubMed:19707553). Implicated in hydroxy radical-mediated cell death induced by hydroxyurea treatment (PubMed:20005847, PubMed:23416055). In conjunction with EDF prevents apoptotic-like death (ALD) in the presence of DNA damaging agents, probably by reducing recA mRNA levels in a non-endonuclease-mediated manner (PubMed:22412352). Other studies (in strains BW25113 and MC4100, the latter makes EDF) demonstrate MazF does not cause PCD but instead bacteriostasis and possibly a dormant state as well as persister cell generation (PubMed:24375411). mRNA interferases play a role in bacterial persistence to antibiotics; overexpression of this protein induces persisters resistant to ciprofloxacin and ampicillin (PubMed:21788497).</text>
</comment>
<comment type="activity regulation">
<text evidence="28">(Microbial infection) RNA cleavage activity is reduced when ADP-ribosylated.</text>
</comment>
<comment type="activity regulation">
<text evidence="9 19 24">Inhibited by Mg(2+) (PubMed:15537630). Stimulated in vitro in a concentration-dependent fashion by EDF, which is able to overcome inhibition by cognate antitoxin MazE (PubMed:21419338). The TA system is antagonized by stress response kinase SrkA, but probably not by phosphorylation of MazF (PubMed:23416055).</text>
</comment>
<comment type="subunit">
<text evidence="3 5 19 27 30">Probably a dimer. Forms a heterohexamer composed of alternating toxin and antitoxin homodimers MazF(2)-MazE(2)-MazF(2). The binding site of MazE and ssRNA or ssDNA are largely overlapping; the presence of only 1 MazE molecule inhibits mRNA endoribonuclease activity. Binds to EDF but not a mutated EDF (NNGNN) (PubMed:21419338).</text>
</comment>
<comment type="induction">
<text evidence="3 6 11 21 25 29 30">Expressed in exponentially growing cells. Induction has been reported to occur after amino acid starvation in a ppGpp-independent fashion and to be Lon protease-dependent (PubMed:12972253), but also to not occur after amino acid starvation and to be regulated by ppGpp (PubMed:8650219). Also induced in M9 minimal medium and by chloramphenicol treatment (PubMed:21944167). MazE alone and in combination with MazF, represses transcription of the mazE-mazF operon. Fis activates transcription. Part of the relA-mazE-mazF-mazG operon, there is also a second mazE-mazF specific promoter which is negatively autoregulated (PubMed:2844820, PubMed:8650219). Operon induced by ectopic expression of toxin RelE; operon induction by amino acid starvation requires the relBEF operon (PubMed:23432955).</text>
</comment>
<comment type="domain">
<text evidence="33">Loop 1 (residues 17-28) effects catalytic activity while recognition of the ACA cleavage site is influenced by loop 2 (residues 53-61). Alterations of loop 2 generate new cleavage sites in addition to retaining the original cleavage site.</text>
</comment>
<comment type="PTM">
<text evidence="28">(Microbial infection) ADP-ribosylated by enterobacteria phage T4.</text>
</comment>
<comment type="disruption phenotype">
<text evidence="4 6 7 8 17 18 20 22 24 26 30">Decreased sensitivity to dramatic intracellular increases of ppGpp. Cells missing mazE-mazF survive high temperature, various DNA-damaging agents and H(2)O(2) exposure better than wild-type cells. Cells missing mazE-mazF produce more P1 phage than wild-type cells, while introduction of lysogens into a growing non-lysogenic disruption culture is lethal (PubMed:15316771). Cells missing mazE-mazF show reduced biofilm formation, and survive antibiotic treatment in log phase better than wild-type cells (PubMed:11222603, PubMed:19707553). However lag phase cells disrupted only for mazF had a lower survival rate than wild-type cells (PubMed:24375411). Cells missing mazE-mazF survive hydroxyurea treatment better than wild-type; further disruption of relE-relB and tonB yields even better survival (PubMed:20005847). Cells missing mazE-mazF undergo an apoptotic-like death (ALD) upon DNA damage characterized by membrane depolarization and DNA fragmentation; further disruption of recA prevents membrane depolarization (PubMed:22412352). Unlike the single srkA disruption mutant, a triple srkA-mazE-mazF disruption mutant shows no hyperlethality in the presence of nalidixic acid or UV light, suggesting SrkA has a negative effect on MazF (PubMed:23416055). mRNA interferases play a role in bacterial persistence to antibiotics; as 10 mRNA interferases are successively deleted reduced levels of persisters are generated (PubMed:21788497).</text>
</comment>
<comment type="biotechnology">
<text evidence="10">Can be used to produce large quantities of a single protein if the gene coding for the protein does not contain any ACA codons. Up to 90% of expressed bacterial cellular protein can be the target, which can be produced for up to 4 days. The system also works in eukaryotic cells.</text>
</comment>
<comment type="similarity">
<text evidence="32">Belongs to the PemK/MazF family.</text>
</comment>
<comment type="caution">
<text evidence="14">Strain K12 / MG1655 is deficient in both production and response to EDF, unlike strains K12 / MC4100, K12 / W3110 and K12 / K38, all of which make and respond to EDF.</text>
</comment>
<dbReference type="EC" id="3.1.27.-" evidence="9"/>
<dbReference type="EMBL" id="D16450">
<property type="protein sequence ID" value="BAA03918.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="J04039">
<property type="protein sequence ID" value="AAA03239.1"/>
<property type="molecule type" value="Unassigned_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U29580">
<property type="protein sequence ID" value="AAA69292.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U00096">
<property type="protein sequence ID" value="AAC75824.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP009048">
<property type="protein sequence ID" value="BAE76856.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="PIR" id="B49339">
<property type="entry name" value="B49339"/>
</dbReference>
<dbReference type="RefSeq" id="NP_417262.1">
<property type="nucleotide sequence ID" value="NC_000913.3"/>
</dbReference>
<dbReference type="RefSeq" id="WP_000254738.1">
<property type="nucleotide sequence ID" value="NZ_LN832404.1"/>
</dbReference>
<dbReference type="PDB" id="1UB4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A/B=2-111"/>
</dbReference>
<dbReference type="PDB" id="3NFC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B/C/D/E/F=1-111"/>
</dbReference>
<dbReference type="PDB" id="5CK9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=1-111"/>
</dbReference>
<dbReference type="PDB" id="5CKB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=1-111"/>
</dbReference>
<dbReference type="PDB" id="5CKD">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A/B=1-111"/>
</dbReference>
<dbReference type="PDB" id="5CKE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B=1-111"/>
</dbReference>
<dbReference type="PDB" id="5CKF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=1-111"/>
</dbReference>
<dbReference type="PDB" id="5CKH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A/B=1-111"/>
</dbReference>
<dbReference type="PDB" id="5CO7">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.49"/>
<property type="chains" value="A/B/C/D/E/F=1-111"/>
</dbReference>
<dbReference type="PDB" id="5CQX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.63"/>
<property type="chains" value="A/B=1-111"/>
</dbReference>
<dbReference type="PDB" id="5CQY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.48"/>
<property type="chains" value="A/B=1-111"/>
</dbReference>
<dbReference type="PDB" id="5CR2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C=1-111"/>
</dbReference>
<dbReference type="PDBsum" id="1UB4"/>
<dbReference type="PDBsum" id="3NFC"/>
<dbReference type="PDBsum" id="5CK9"/>
<dbReference type="PDBsum" id="5CKB"/>
<dbReference type="PDBsum" id="5CKD"/>
<dbReference type="PDBsum" id="5CKE"/>
<dbReference type="PDBsum" id="5CKF"/>
<dbReference type="PDBsum" id="5CKH"/>
<dbReference type="PDBsum" id="5CO7"/>
<dbReference type="PDBsum" id="5CQX"/>
<dbReference type="PDBsum" id="5CQY"/>
<dbReference type="PDBsum" id="5CR2"/>
<dbReference type="SMR" id="P0AE70"/>
<dbReference type="BioGrid" id="4262300">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1086">
<property type="entry name" value="mazEF toxin-antitoxin complex"/>
</dbReference>
<dbReference type="IntAct" id="P0AE70">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="STRING" id="511145.b2782"/>
<dbReference type="BindingDB" id="P0AE70"/>
<dbReference type="ChEMBL" id="CHEMBL1795096"/>
<dbReference type="PaxDb" id="P0AE70"/>
<dbReference type="PRIDE" id="P0AE70"/>
<dbReference type="EnsemblBacteria" id="AAC75824">
<property type="protein sequence ID" value="AAC75824"/>
<property type="gene ID" value="b2782"/>
</dbReference>
<dbReference type="EnsemblBacteria" id="BAE76856">
<property type="protein sequence ID" value="BAE76856"/>
<property type="gene ID" value="BAE76856"/>
</dbReference>
<dbReference type="GeneID" id="947252"/>
<dbReference type="KEGG" id="ecj:JW2753"/>
<dbReference type="KEGG" id="eco:b2782"/>
<dbReference type="PATRIC" id="fig|1411691.4.peg.3953"/>
<dbReference type="EchoBASE" id="EB1229"/>
<dbReference type="EcoGene" id="EG11249">
<property type="gene designation" value="mazF"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4105MZG">
<property type="taxonomic scope" value="Bacteria"/>
</dbReference>
<dbReference type="eggNOG" id="COG2337">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000290185"/>
<dbReference type="InParanoid" id="P0AE70"/>
<dbReference type="KO" id="K07171"/>
<dbReference type="PhylomeDB" id="P0AE70"/>
<dbReference type="BioCyc" id="EcoCyc:EG11249-MONOMER"/>
<dbReference type="BioCyc" id="ECOL316407:JW2753-MONOMER"/>
<dbReference type="BioCyc" id="MetaCyc:EG11249-MONOMER"/>
<dbReference type="EvolutionaryTrace" id="P0AE70"/>
<dbReference type="PRO" id="PR:P0AE70"/>
<dbReference type="Proteomes" id="UP000000318">
<property type="component" value="Chromosome"/>
</dbReference>
<dbReference type="Proteomes" id="UP000000625">
<property type="component" value="Chromosome"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004521">
<property type="term" value="F:endoribonuclease activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006402">
<property type="term" value="P:mRNA catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030308">
<property type="term" value="P:negative regulation of cell growth"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051291">
<property type="term" value="P:protein heterooligomerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0009372">
<property type="term" value="P:quorum sensing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006417">
<property type="term" value="P:regulation of translation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016075">
<property type="term" value="P:rRNA catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="DisProt" id="DP00299"/>
<dbReference type="Gene3D" id="2.30.30.110">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR003477">
<property type="entry name" value="PemK-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR011067">
<property type="entry name" value="Plasmid_toxin/cell-grow_inhib"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR33988">
<property type="entry name" value="PTHR33988"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02452">
<property type="entry name" value="PemK_toxin"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0013">ADP-ribosylation</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0255">Endonuclease</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0540">Nuclease</keyword>
<keyword id="KW-0673">Quorum sensing</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0346">Stress response</keyword>
<keyword id="KW-1277">Toxin-antitoxin system</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0810">Translation regulation</keyword>
<feature type="chain" description="Endoribonuclease toxin MazF" id="PRO_0000201897">
<location>
<begin position="1"/>
<end position="111"/>
</location>
</feature>
<feature type="region of interest" description="Loop 1, participates in catalytic activity" evidence="33">
<location>
<begin position="17"/>
<end position="28"/>
</location>
</feature>
<feature type="region of interest" description="Loop 2, involved in substrate recognition" evidence="33">
<location>
<begin position="53"/>
<end position="61"/>
</location>
</feature>
<feature type="modified residue" description="ADP-ribosylarginine" evidence="28">
<location>
<position position="4"/>
</location>
</feature>
<feature type="mutagenesis site" description="Changes loop 1 to poly-G; loss of endoribonuclease activity." evidence="23">
<original>FDPTKGSEQAGH</original>
<variation>GGGGGGGGGGG</variation>
<location>
<begin position="17"/>
<end position="28"/>
</location>
</feature>
<feature type="mutagenesis site" description="Changes loop 1 to MazF6 M.tuberculosis sequence; loss of endoribonuclease activity." evidence="23">
<original>FDPTKGSEQAGH</original>
<variation>LGPPSGSQPAKR</variation>
<location>
<begin position="17"/>
<end position="28"/>
</location>
</feature>
<feature type="mutagenesis site" description="Changes loop 1 to MazF M.xanthus sequence; loss of endoribonuclease activity." evidence="23">
<original>FDPTKGSEQAGH</original>
<variation>PDDSRGPVPSYS</variation>
<location>
<begin position="17"/>
<end position="28"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduces toxicity, about 10-fold less RNA cleavage activity. Expression in the presence of wt MazF has a dominant-negative phenotype, causing cell death as it titrates out the MazE antitoxin; still activates operon transcription." evidence="12 26">
<original>E</original>
<variation>A</variation>
<location>
<position position="24"/>
</location>
</feature>
<feature type="mutagenesis site" description="No changes in toxicity." evidence="26">
<original>H</original>
<variation>A</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="mutagenesis site" description="Changes loop 2 to poly-G; reduces endoribonuclease activity, alters cleavage sites." evidence="23">
<original>TQSKGYPFE</original>
<variation>GGGGGGGG</variation>
<variation>GGGGGGGGGGG</variation>
<location>
<begin position="53"/>
<end position="61"/>
</location>
</feature>
<feature type="mutagenesis site" description="Changes loop 2 to MazF M.xanthus sequence; reduces endoribonuclease activity, alters cleavage sites." evidence="23">
<original>TQSKGYPFE</original>
<variation>SNLHRASEPGN</variation>
<location>
<begin position="53"/>
<end position="61"/>
</location>
</feature>
<feature type="mutagenesis site" description="Changes loop 2 to MazF6 M.tuberculosis sequence; reduces endoribonuclease activity, alters cleavage sites." evidence="23">
<original>TQSKGYPFE</original>
<variation>SNTALAAMPGN</variation>
<location>
<begin position="53"/>
<end position="61"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="11"/>
<end position="15"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="19"/>
<end position="22"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="29"/>
<end position="33"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="37"/>
<end position="43"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="46"/>
<end position="53"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="61"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="66"/>
<end position="69"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="72"/>
<end position="74"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="75"/>
<end position="77"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="79"/>
<end position="81"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="83"/>
<end position="86"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="89"/>
<end position="93"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="96"/>
<end position="110"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5CKD"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5CQX"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11071896"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11222603"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12718874"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12972253"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15150257"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15316771"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15537630"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15837428"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16390452"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16413577"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17962566"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18310334"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18854355"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19251848"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19707553"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20005847"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21419338"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21788497"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21944167"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22412352"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23280569"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23416055"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23432955"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24375411"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25564525"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26395283"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2844820"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8650219"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15537630"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000305"/>
<evidence key="33" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="23280569"/>
</source>
</evidence>
<sequence length="111" mass="12098" checksum="1579C867DD6B96AC" modified="2005-12-06" version="1">
MVSRYVPDMGDLIWVDFDPTKGSEQAGHRPAVVLSPFMYNNKTGMCLCVPCTTQSKGYPF
EVVLSGQERDGVALADQVKSIAWRARGATKKGTVAPEELQLIKAKINVLIG
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>